Home » Topics » Regulatory

Regulatory
RSS

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

ASA + ibuprofen combination effective in treating Listeria infection in mice

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

American Biogenetic Sciences' blood clot diagnostic test cleared for marketing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.